Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-11-06
DOI
10.1038/s41598-017-15338-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins
- (2017) Senko Tsukuda et al. HEPATOLOGY
- Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity
- (2017) Satomi Shimura et al. JOURNAL OF HEPATOLOGY
- First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
- (2016) Antje Blank et al. JOURNAL OF HEPATOLOGY
- Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
- (2016) Pavel Bogomolov et al. JOURNAL OF HEPATOLOGY
- Entry of hepatitis B and hepatitis D virus into hepatocytes: Basic insights and clinical implications
- (2016) Wenhui Li et al. JOURNAL OF HEPATOLOGY
- Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options
- (2016) Florian A. Lempp et al. Nature Reviews Gastroenterology & Hepatology
- Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes
- (2016) Eloi R. Verrier et al. Cell Reports
- Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na+-dependent taurocholate cotransporting polypeptide activity
- (2015) Xue-jun Wang et al. ANTIVIRAL RESEARCH
- Quantitative NTCP pharmacophore and lack of association between DILI and NTCP Inhibition
- (2015) Zhongqi Dong et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- A substrate pharmacophore for the human sodium taurocholate co-transporting polypeptide
- (2015) Zhongqi Dong et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide
- (2015) Manabu Kaneko et al. JOURNAL OF VIROLOGY
- Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism
- (2014) Nicola Oehler et al. HEPATOLOGY
- An update on HDV: virology, pathogenesis and treatment
- (2013) Mónica V Alvarado-Mora et al. ANTIVIRAL THERAPY
- Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
- (2013) Yi Ni et al. GASTROENTEROLOGY
- Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts
- (2013) Alexa Schieck et al. HEPATOLOGY
- Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor
- (2013) Shirin Nkongolo et al. JOURNAL OF HEPATOLOGY
- Structure–Activity Relationship for FDA Approved Drugs As Inhibitors of the Human Sodium Taurocholate Cotransporting Polypeptide (NTCP)
- (2013) Zhongqi Dong et al. MOLECULAR PHARMACEUTICS
- Chicago sky blue 6B, a vesicular glutamate transporters inhibitor, attenuates methamphetamine-induced hyperactivity and behavioral sensitization in mice
- (2012) Zongsheng He et al. BEHAVIOURAL BRAIN RESEARCH
- Monitoring bile acid transport in single living cells using a genetically encoded Förster resonance energy transfer sensor
- (2012) Lieke M. van der Velden et al. HEPATOLOGY
- Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes
- (2012) Anja Meier et al. HEPATOLOGY
- Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health
- (2012) Karin Dilger et al. JOURNAL OF HEPATOLOGY
- Virology of Hepatitis D Virus
- (2012) John Taylor SEMINARS IN LIVER DISEASE
- In Silico Identification of Potential Cholestasis-Inducing Agents via Modeling of Na+-Dependent Taurocholate Cotransporting Polypeptide Substrate Specificity
- (2012) Rick Greupink et al. TOXICOLOGICAL SCIENCES
- Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
- (2012) Huan Yan et al. eLife
- Homo- and hetero-dimeric architecture of the human liver Na+-dependent taurocholate co-transporting protein
- (2011) Ingrid T. G. W. Bijsmans et al. BIOCHEMICAL JOURNAL
- Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation
- (2011) Marc Lütgehetmann et al. HEPATOLOGY
- Primary biliary cirrhosis
- (2009) Keith D. Lindor et al. HEPATOLOGY
- Bile acid transporters
- (2009) Paul A. Dawson et al. JOURNAL OF LIPID RESEARCH
- Fine Mapping of Pre-S Sequence Requirements for Hepatitis B Virus Large Envelope Protein-Mediated Receptor Interaction
- (2009) A. Schulze et al. JOURNAL OF VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now